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LITERATURE REVIEW / BACKGROUND 
 
 
 Viruses are relatively new organisms to us, only first being discovered in the late 
19th century.  Jacob Henle postulated in 1840 that there was a very small infectious agent 
that could not be seen with a microscope, unlike the protozoa, fungi, and bacteria which 
had been observed in this manner.  His hypothesis would not be proven true for another 
50-60 years.  In 1892, Dimitri Ivanofsky passed extracts of tobacco mosaic infected 
leaves through the smallest filter known at the time, unglazed porcelain.  He was trying to 
eliminate bacteria, which were bigger than the porcelain pores.  However, he found that 
the filtrate still caused disease in new leaves.  He thus determined that the filter must be 
defective or the disease was caused by a toxin.  In 1898, Martinus Beijerinck, unaware of 
Ivanofsky’s work, also did the same experiment, but came up with a different conclusion.  
He hypothesized that the disease was not caused by a toxin because it was able to grow 
and reproduce in the living plant cells.  Thus, the idea of viruses had been established.  
The term filterable agents was used for classification of this new infectious component, 
but was gradually replaced with the term virus (Latin for “poison”).  Bacteriophages, 
viruses that infect bacteria, were discovered by Frederick Twort (1915) and Felix 
d'Herelle (1917) and have since become important agents in obtaining knowledge about
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viruses as a whole.  This is due to the simplicity of growing the bacteria that they infect 
in the laboratory1, 2.  
 
Even today, the complexity and number of bacteriophages, and other viral 
species, is just beginning to be appreciated.  Studies have been performed to quantify the 
number of bacterial and viral populations in ocean waters.  These findings have shown a 
bacterial concentration of 106 cells/mL and a viral concentration of 107 particles/mL.  
Globally, it has been estimated that at any one time there are 1030 or more phage 
particles, thus surpassing available host organisms by at least one order of magnitude3, 4.  
This would suggest that all living cells are under a constant barrage of viral intrusions.  
There is evidence of this viral-host battle in the fact that the cellular organisms have been 
able to acclimate themselves to coexist with viruses and to support viral or virus-like 
genomes5.  When using the global marine population numbers, calculations of gene 
transfer between organisms occur at a rate of 20 million billion times per second in the 
oceans.  Actual numbers would be less due to smaller transduction efficiency and 
increased phage decay in the ocean versus the laboratory.  However, even a fraction of 
this occurrence taking place still opens the door for an enormous amount of horizontal 
gene transfer from both the virus to the host and from the host to the virus3.  Therefore, 
viruses need to be studied further to fully comprehend the effect that they have on 
cellular organisms. 
 
The most popular molecular bacteriology species, Escherichia coli and Bacillus 
subtilis, are each hosts for about 10 phage species.  Each of these phages varies widely in 
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genome organization, as well as DNA sequencing levels within each group.  If it can be 
generalized that each bacterial species plays host to 10 or more phages, then viruses 
would certainly be the largest uncultivated reservoir of sequence information in the 
biosphere.  A study was conducted to perform random sequencing of viral DNA obtained 
from two uncultured ocean water samples.  The results, combined with statistical 
analysis, showed a presence of 400-7,000 different viral species, depending on sample 
variations, with the most abundant type representing just 3% of the total viral 
population3.  This would indicate that our current knowledge has only begun to scratch 
the surface, so further work needs to be done to explore and understand the interesting 
world of viruses.  
 
Present knowledge of viruses and viral infections has led to increased knowledge 
of cellular processes, cell biology, and genetics.  They have proved important when 
exploited as tools in molecular biology.  One area, in particular, is in protein production 
where bacteriophages are enormously efficient.  Since viral programming is designed to 
carry genetic information into cells, they have been used to replace defective cellular 
genes, such as in gene therapy.  A new field of research is occurring with genetically 
engineered viruses to aid in medical intervention and agricultural applications1.  A more 
comprehensive understanding of phages, in both their processes and structure, can only 
lead to better utilization of this knowledge and the ability to enrich our medical, 
industrial, and agricultural institutions.   
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Viral families are organized by properties that they share with each other.  These 
properties are defined by four different criteria.  The first involves the nucleic acid 
contained within the virion, either DNA or RNA.  The second incorporates the symmetry 
of the capsid, which can be described by three subcategories: helical, icosahedral, and 
complex.  The third property is based on the presence or absence of a lipid membrane, or 
envelope.  The final category is attributed to the dimensions of the virion and viral coat.  
The classification can then further be subdivided by applying knowledge of the genome 
architecture.  The arrangements are divided into single stranded (ss) or double stranded 
(ds) RNA or DNA and whether the DNA is circular or linear2.  Additional partitioning 
can be made via host preference.  However, viruses are real, but the species designations 
are man-made6, and studies leading into this research is showing that these classifications 
might need to be revised.  Bacteriophages, the main focus of this work, have 
representative members in all division types, making them a very diverse group.  
 
Bacteriophages, from the Latin “eaters of bacteria”, range in size from 4 kilobase 
pairs (kbp) to 600 kbp.  Tailed phages make up 96% of this group4.  Currently, there are 
known to be 12 distinct groups of bacteriophages, which are very diverse structurally and 
genetically.  Their mode of replication is similar to all other viruses.  After attaching to a 
specific receptor on the bacterial cell wall, the phage genome enters the cell.  The capsid 
proteins are usually left outside the cell by being stripped off in the entry process or the 
phage uses special viral components to inject the genome into the cell.  Many of the 
tailed phages have a contractile sheath that is utilized like a syringe for genome injection.  
The "head and tail" morphology is unique to the tailed phages and is related to their mode 
 5
of cell penetration.  Some "round" phages (icosahedral or lipid-coated) enter the bacterial 
cell by adhering to flagellae or pili on the host’s cell wall and being drawn in to the cell 
by endocytosis.  After entry, many phage genomes are degraded and destroyed.  This is 
due to protective bacterial mechanisms which depend on the recognition and destruction 
of foreign DNA.  Surviving phage genomes utilize the cellular apparatus for gene 
expression (transcription and translation) to various extents7.  
 
Of all the known viruses, double-stranded DNA (dsDNA) tailed bacteriophages 
are the most common in the biosphere4.  Therefore, these phages can be found in a vast 
array of environments and most likely infect the whole range of bacterial species.  These 
viruses are classified as coliphage and can be regarded as being one super-organism, 
despite differences in morphological features, with the members exchanging genetic 
material globally through recombination8.  Bacteriophage infections are estimated to 
occur at a rate of ~1025 globally per second9.  This has led to the tailed bacteriophages 
having mosaic genomes8, 10, 11.  Mosaicity occurs when one compares two genome 
sequences and finds regions of high sequence similarity with abrupt transitions to 
neighboring regions of little to no similarity11.  This phenomenon points to the fact that 
viral evolution has been influenced by horizontal transfer, as well as impacting bacterial 
evolution through infection.  Consequently, understanding more about viral evolution and 
origins will allow for more familiarity of viral processes as a whole.     
 
This thesis involves icosahedral dsDNA bacteriophages with a lipid membrane 
and no tail, an individual property that segregates them from the tailed dsDNA 
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bacteriophages.  More specifically, this study focuses on the family Tectiviridae, 
containing those isolates that infect Gram-negative hosts (PRD1, PR3, PR4, PR5, L17, 
and PR772) and Gram-positive hosts (Bam35, Ap50, and phi NS11).  These isolates were 
originally placed together for morphological reasons5, even though their hosts diverged 
about two billion years ago12.  Unlike the mosaicity of the tailed bacteriophages, PRD1 
and all of the PRD1-like isolates are almost identical in their genomes, despite isolation 
at different dates and locations from around the world.  Also, Bam35 and one of its 
isolates, GIL01, have proven to have essentially equivalent genome sequences5.  This 
family is of interest due to the lipid membrane, which lies beneath their protein capsid.  
The membrane substitutes for the tail, seen in the majority of phages, by forming a tube 
with the membrane to generate a tail to allow for infection of its host.  This aspect of their 
morphology is one reason they were investigated so as to study the protein-membrane 
interactions13.  Other studies of interest focus on the viral structure.  Determining the 
configuration of the virus as a whole can give insights into the assembly, and even 
disassembly, of the virus.  Knowledge of the framework of the virus and its individual 
components can lead to further understanding of the functions of each; such as binding 
sites, host cell and viral component fusion, and packaging, among others.  The 
uniqueness in structure of the Tectiviridae family makes it an interesting candidate for 
further studies into organization and biogenesis14.   
 
PRD1 is the type species for this family and has been studied in detail.  It is a lytic 
phage13, 15, which means that the cells that it infects are destroyed in the process, due to 
cell membrane disruption.  Structures have been determined for its coat protein, receptor-
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binding protein and virion14, 16-23.  The virus consists of an icosahedral protein coat with 
receptor-binding spikes at its vertices.  Underneath the capsid lies the membrane, which 
encloses a linear 14,935 bp genome5 (see Figure 1-1).  The capsid protein, known as P3, 
is a trimeric molecule.  It is composed of two eight-stranded viral jelly rolls, or β-barrels, 
in each 394 residue subunit.  The capsid measures 698 Å between opposing vertices.  The 
organization of the coat proteins is in a pseudo T=25 arrangement with 240 P3 trimers 
that make up the 20 facets and a P31 pentamer located at each 5-fold vertex19, 21, 24.  
There are twelve total vertices on this phage, eleven regular vertices and one special 
packaging vertex.  This packaging vertex functions as a channel through which the 
genome DNA is packaged into the empty particles25.    
 
Figure 1-1. Schematic of the PRD1 virion.  
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Another important member of this family is Bam35 (14,935 bp).  It has essentially 
an identical capsid organization as PRD1, as recently revealed by a 7.3 Å resolution 
image reconstruction from cryo-electron microscopy (cryo-EM) images26.  Furthermore, 
its capsid protein, also denoted P3, is predicted to be similar to the coat of PRD127.  
However, the two proteins share a limited amount of sequence similarity, despite a 
comparable protein size (356 residues for Bam35 P3 compared with 394 residues for 
PRD1 P3).  The sequences of the P3 proteins share only 16% identity and 31% similarity.  
The sequence of one capsid protein will not retrieve the other when performing a PSI-
BLAST28 search.  Nevertheless, 3D-PSSM29, a program that searches for structures 
congruent with the sequence and secondary structure estimates, has predicted with >95% 
confidence that the folds are analogous.  CLUSTAL X30 was used to align the two 
sequences and introduce gaps into the shorter Bam35 P3 sequence to optimize alignment.  
Due to the nominal sequence similarity, specific alignment was not possible.  This 
alignment was evaluated by threading the Bam35 P3 sequence onto the structure of 
PRD1 P3.  However, the sets of matching residues and their similar spacing were able to 
secure the alignment.  The modeling showed that the Bam35 P3 sequence could adapt to 
the PRD1 P3 crystal structure.   
 
The major focus of the resemblance between these two phages comes from the 
double barrel trimer motif in the major coat proteins.  The exact composition of this 
structural aspect will be discussed in more detail in Chapter 2.  The importance of this 
similarity is not just that it can be seen within these two species, but that structural studies 
have now found the double barrel trimer coat protein apparent in several other viruses, 
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with hosts spanning across the tree of life and forming a proposed lineage.  Paramecium 
bursaria chlorella virus 1 (PBCV-1), a member of the family Phycodnaviridae, infects 
algae.  The solved structure of its capsid protein, Vp54, has shown the presence of the 
double barrel trimer31.  Recently, sulfolobus turreted icosahedral virus (STIV) has also 
shown this same structural aspect.  STIV infects an archaeabacterium that is known to 
grow optimally at pH 2-4 and >80°C32.  Adenovirus was one of the first to show the 
double barrel trimer within it major capsid protein structure.  It belongs to the family 
Adenoviridae and has mammalian and avian hosts33, 34.  Models have been created for 
other viruses which were acquired with literature and PSI-BLAST searches.  Chilo 
iridescent virus (CIV) is an insect infecting member of the Iridoviridae family, which 
infects vertebrates (fish, amphibian, and reptile) and invertebrates (insects).  The 
threading of its coat protein, P50, onto the PBCV-1 Vp54 crystal structure shows the 
preservation of the double barrel trimer and major differences in the sequence alignments 
occurring in loop regions.  The coat protein, P72, of African swine fever virus (ASFV), 
the sole member of Asfarviridae, is also consistent with the double-barrel framework and 
is a candidate for this proposed lineage.  The recently discovered mimiviruses, infecting 
amoebae, and the ascoviruses, infecting moth and butterfly larva, have also shown 
modeling results that indicate that they too belong in this viral line13. 
 
It is proposed that convergence of structure to perform the same function is highly 
improbable.  Extremely similar structures with very different amino acid sequences is 
most likely the result of divergent, instead of convergent, evolution35, 36.  This structural 
similarity, despite differences in hosts and genome sequences, points to an overall 
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divergence theory for PRD1 and Bam35.  The divergence theory stems from the belief 
that viruses were present before the tree of life (see Figure 1-2) diverged into the 
branches that we observe today.  There is a belief that viruses do not possess a single 
root, but instead different viral lineages span out and complement all branches that we 
currently observe on the cellular tree of life.  The fact that viruses were present in 
primeval times means that they have been able to adapt to their hosts and influence the 
host’s evolution. 
 
If this theory is true, we need to be able to explain the conservation of structural 
aspects when all other features, such as genome sequence and host preference, show little 
to no similarities.  This can be done with the concept of a viral “self”.  The self preserves 
efficiency when interacting with hosts and yet conserves viral structures and functions37.  
It would contain determinants, transcended from the viral ancestor, which would encode 
for vital structural properties of the virion.  These would be items such as architecture and 
even genome packaging, which would lead to phylogenetic relationships among the 
viruses.  Characteristics such as host recognition and adaptation are not part of the viral 
self, instead they are most likely obtained through lateral gene transfer from the host, and 




Figure 1-2. Tree of Life. 
  
 The main goal of this study is to find evidence to support the idea of the 
divergence theory.  The first part of the study focuses on trying to show the true 
relationship of the two P3 coat proteins of the known PRD1 and the studied Bam35 
(Chapter 2).  The second part of the study focuses on a portal protein, located on the 
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special packaging vertex of PRD1, known as P6 (Chapter 3).  The expectation here is to 
expand the idea of conserved viral capsid structures to other vital viral structures and 
functions.  By adding additional structures of the major components of these dsDNA 
icosahedral viruses, we can further explain the similarities and differences between them 
and discover the characteristics that arose from the ancestral virus.  Furthermore, these 
similarities can lead to a better understanding of how these viruses assemble and package 
their genomes.  Perhaps it is possible to manipulate these “commonalities” to prevent the 







2.1 Introduction  
 
 Bacteriophage Bam35, which infects Gram-positive bacteria, is a member of the 
Tectiviridae family.  It is specific for Bacillus thuringiensis, a soil bacterium.  The 
genome consists of linear dsDNA, which has 14,935 bp13, 27 with 5’-covalently linked 
terminal proteins.  It is a temperate phage, which means that it can either lyse all of the 
infected bacterial cells or remain as a linear dsDNA plasmid in the bacterium and 
replicated along with its host38. 
 
 Much is known genetically, biochemically, and structurally about the type species 
of the Tectiviridae family, bacteriophage PRD1, as detailed in Chapter 15, 39.  The major 
coat protein, P3, as well as other proteins have been determined by X-ray 
crystallography, and the entire PRD1 virion has been determined with both X-ray 
crystallography and cryo-EM image reconstructions14, 16-21.  Models have been developed 
to give a more in depth picture on various structures that make up this virus.  Despite 
differences in host preference and genome sequence, PRD1 and Bam35 have been placed 
in the same family due to gross morphological reasons.  Two other Gram-positive 
infecting members exist in this family, AP50 and phi NS11.  The anthracis phage, AP50, 
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is not an ideal model system and phi NS11 is no longer available.  Thus, Bam35 was the 
ideal candidate of these three to try and ascertain if the previously linked Tectivirus-
adenovirus lineage is maintained16 and to determine whether this phage belongs to the 
same family as PRD1. 
 
 The divergence of Gram-positive and Gram-negative bacteria is thought to have 
occurred one to two billion years ago12, 40.  Therefore, any present resemblance amongst 
their phages would be of great interest.  Negative-stain electron microscopy has shown 
that the Bam35 virion morphology closely resembles similarly derived images of the 
virion of PRD141.  As previously mentioned, the genome lengths of each phage are 
almost identical and they are similarly organized (See Figure 2-1).  It has been discovered 
that the capsids have similar diameters.  Bam35 has an internal membrane that is 
congruent with PRD1.  This means that Bam35 has an equitable volume to PRD1 in 
which DNA packaging can occur.   
 
 The major interest in this study is to be able to crystallize and obtain the atomic 
structure of the major coat protein, P3, of Bam35.  This can then be compared to the 
previously determined structure of the P3 protein of PRD114 and the other structures that 
fall into this order (adenovirus hexon, PBCV-1 Vp54, and STIV MCP) in order to affirm 
the divergence theory.  The coat structures previously mentioned have the conservation  
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Figure 2-1. Genome organization of Bam35c (top) and PRD1 (middle).  Note the similar genome 
length as measured by the kbp ruler (bottom).   
of a double-barrel trimer.  A double-barrel trimer, as seen in PRD1, occurs when two 8-
stranded viral jelly rolls, or β-barrels, are arranged in tandem in a single subunit.  The 
jelly roll contains eight β-strands in sequence (B, C, D, E, F, G, H, and I).  The A strand 
is omitted for historical reasons since the first example of a single viral jelly roll from 
tomato bushy stunt virus contained an extra strand before the jelly roll42.  The jelly roll is 
folded down the middle, which causes E to pair up antiparallel with F via hydrogen 
bonds, D bonds with G, C bonds with H, and B with I.  Hydrogen bonds occur within the 
sheet, but not at the edges.  Therefore, B does not bond with C and F does not bond with 
G.  Two sheets with four strands, BIDG and CHEF, comprise the folded jelly roll (See 
Figure 2-2).  This situation makes it unique, unlike the true barrel seen with the β/α motif.  
The strands are variable in length, but the width and separation of the sheet is rather 
stable.  There are essentially four different ways in which an eight stranded jelly roll 
could fold43.  However, only the form above can be seen in spherical viruses.  This 
conserved form of folding of the major capsid protein, seen in several viruses of different 
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hosts, implies that the divergence theory can hold true.  Although loss of similarity in 




Figure 2-2.  Jelly roll fold.  The initial protein chain for the jelly roll contains 8 β−strands in sequence 
(top).  The jelly roll folds down the middle to pair up B & I, C & H, D & G, and E & F (middle).  
Finally, the jelly roll folds (or rolls like a jelly roll) so that one sheet contains BIDG and another sheet 
contains CHEF (bottom).  Strands G and F do not hydrogen bond. 
 
 
It is known that the PRD1 P3 structure is a trimeric molecule with each subunit 
composed of two eight stranded viral jelly rolls, or β-barrels.  The protein is made up of 
394 residues.  The P3 protein of Bam35 is made up of 356 residues.  While the two show 
minimal sequence similarity (only 16% identity and 31% similarity), the folds are 
anticipated to be similar with >95% confidence by the program 3D-PSSM29.  To prove 
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the assumption of similar folding and structure, a model of Bam35 was performed by 
threading the sequence onto the known structure of PRD1.  CLUSTAL X30 was used to 
insert gaps into the Bam35 sequence to optimize alignment.  This model (see Fig 2-3 and 
2-4) showed a conservation of the double barrel as a building block to the capsid protein, 
which could not have been determined from the sequence alignment alone13. 
We hope to show that the above model of Bam35 P3 is indeed correct when 
crystallization and structure determination are performed.  In doing so, we expect to 
enhance the evidence that the divergence theory is correct and that an icosahedral dsDNA 
viral ancestor does exist, from which a viral lineage can be traced.  To determine the 
structure of Bam35 P3, it is important to have good expression of the Bam35 P3 
molecule, to obtain it in high purity, and to develop well-formed and reproducible 




Figure 2-3.  Single subunit of PRD1 P3.  This gives a detailed view of the jelly roll fold for one of the 




Figure 2-4.  P3 structure of PRD1 and model of Bam35.  (A) PRD1 P3 trimer structure (B) Bam35 P3 
trimer model 
 
    
2.2 Research Design 
 
 
Culture and Over-Expression of Protein P3: 
For the growth of the Bam35 P3 protein, E. coli strain HMS174 (DE3) (pSK50) 
was used with the cloning vector being pJJ2 that was developed by our collaborator Dr. 
Jaana Bamford (University of Jyväskylä, Finland).  A small amount was taken from the 
frozen stock (-80°C) solution and was streaked on a Petri dish containing LB (Luria 
Bertani) agar with Ampicillin.  This dish was then incubated at 37°C for 24 hours. 
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A colony was picked and placed into a 100 mL baffled bottom Nalgene flask.  
This flask contained 20 mL of Luria broth spiked with 150 μg/mL of ampicillin.  The 
flask, as well as all others in the growing process, was capped and the cap was opened a 
quarter of a turn to allow for adequate oxygenation.  This was then placed in the 
Barnstead International Max Q 5000 incubator/shaker and incubated overnight at 37°C 
and 200 rpm.  The next day, the overnight culture was placed into a 1 L baffled bottom 
Nalgene or glass flask containing 480 mL of Luria broth spiked with 150 μg/mL of 
ampicillin.  This was allowed to incubate at 28°C and 200 rpm until proper optical 
density was reached (OD600 ≈ 0.8).   
 
The temperature was reduced to 18°C one hour before addition of isopropyl-beta-
D-thiogalactopyranoside (IPTG), at a concentration of 1 mM, to induce the recombinant 
protein expression.  The culture was maintained at 18°C and 200 rpm overnight.  The 
cells were pelleted (Beckman Coulter Allegra X-15R, 4500 rpm, 30 min, 4°C), collected 
into two 50 mL conical tip tubes, and each was re-suspended in approximately 10 mL of 
20 mM Tris-HCl (pH 7.2) to be later purified.   
 
Different variations of media were explored for culturing E. coli.  When I first 
began this project, the media was ordered as a pre-made solution from Ward’s through 
VWR.  It provided for excellent culturing and protein production.  However, it sometimes 
took awhile to receive the shipment and it was decided to look for ways to cut costs.  So, 
a premixed powdered form (Amresco) of the media was ordered, which contained yeast 
extract, tryptone and sodium chloride in a 2:1:2 ratio.  For a 1 L solution, 25 g of the 
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powder needed to be combined with distilled water and autoclaved at 120°C and 15 psi 
for about 15 minutes.  This combination did not give the same results as the VWR media, 
so it was decided to add glucose to try to increase the bacterial production.  In the 
beginning, 0.1 % glucose was added to the media mixture.  Later, the addition was 
increased to 1% glucose.  After several trials of getting very low yields in protein 
production, a determination of the problem needed to be made.  Three batches of media 
were prepared with 0%, 0.1%, and 1% glucose and all were cultured under the same 
conditions.  It was also decided to compare the previous VWR purchased media with our 
formulation and to test against a formulation available through Sigma as well.  We have 
never been able to determine all of the components available in the VWR media, but 
Sigma let their formulation be known and the components could be purchased 
individually.  The Sigma media was made up of yeast extract, tryptone, and sodium 
chloride and was filtered through a 0.2 μm filter, instead of being autoclaved.  Three 
batches of bacteria in each of the three broths were cultured under the same conditions.  
The Sigma formulation was noted as giving comparable results to the VWR media.  Four 
batches of media were then prepared for further analysis of the Sigma formulation.  Two 
were made up of the same three components, but one was autoclaved while the other was 
filtered.  Two other batches had the addition of 0.1% glucose with one treated by 
autoclaving while the other was filtered.  This trial showed the best result to be the batch 
with no glucose added and being autoclaved.  After narrowing down these conditions, we 




Isolation and Purification of Protein P3: 
The original protocol called for using a French press to isolate the P3 protein from 
the collected cells.  This technique was too cost prohibitive, so it was replaced with 
sonication.  A Branson Sonifier 150 set at level three was used for a total of two minutes.  
The sample was sonicated for one minute and allowed to cool down (approximately 5 
minutes) before sonicating for the other minute.   
 
The cell debris was centrifuged (Beckman Coulter Allegra X-15R, 4500 rpm, 30 
min, 4°C) and the supernatant was decanted into a 15 mL conical tip vial.  A sample was 
taken for sodium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-PAGE).   
The supernatant was further clarified by centrifugation (Beckman Coulter Allegra X-15R, 
4500 rpm, 2-17 hr, 4°C) and a sample was taken for SDS-PAGE.   
 
A 5 mL Pharmacia HiTrap Q cation column was equilibrated by applying 25 mL 
of 20 mM Tris-HCl (pH 7.2) with a pump into the column.  The sample was then applied 
in the same way and the flow through was collected.  The column was washed with 10 
mL of 20 mM Tris-HCl (pH 7.2), with the flow through being collected in three equal 
fractions.  The column was then washed with 25 mL of 1 M NaCl followed by 50 mL of 
20 mM Tris-HCl (pH 7.2) to reequilibrate the column.  Samples were taken from all 
collections to run on SDS-PAGE.   
 
Next, a 5 mL Pharmacia HiTrap SP anion column was used.  The column was 
equilibrated as above and the combined flow throughs were applied to the column.  This 
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column was then placed onto the Bio-Rad BioLogic DuoFlow system.  The buffers used 
are 40 mM Tris base, 40 mM Tris-HCl, 2 M NaCl, and de-ionized water.  All buffers 
were degassed prior to placing them into the system.  The program was set to collect 1 
mL fractions and run at pH 7.2 during the course of the run.  First, an isocratic flow was 
used with 0% salt for a volume of 5 mL at 1 mL/min.  Next, a linear gradient of 0-30% (0 
mM – 300 mM) salt ran for a volume of 30 mL at 1 mL/min.  This was followed by an 
isocratic flow of 100% (1 M) salt for 5 mL at 1 mL/min.  A final wash of the column 
came with an isocratic flow of 0% salt for 10 mL at 1 mL/min.  Samples (20 μL) were 
taken for SDS-PAGE from the indicated fractions corresponding with the peak(s) on the 
chromatogram determined by absorbance at 254 nm.  Desired fractions were combined 
based on the findings of the SDS-PAGE gel. 
 
The SDS-PAGE gels showed several bands in addition to the P3 protein present 
in the purified solution.  Mass spectroscopy was performed to identify the other bands 
present.  It was discovered that the other bands were still all associated with Bam35.  This 
led us to believe that during the isolation of the P3 from its bacterial host, the protein was 
being cleaved at different intervals, possibly by cellular proteases.  This led us to look at 
the possibility of using protease inhibitors.  A cocktail of three protease inhibitors was 
initially used, comprised of leupeptin, pepstatin, and phenylmethanesulphonylfluoride 
(PMSF).  Stock solutions were made by dissolving 2 mg of leupeptin in 1 mL of distilled 
water, dissolving 1 mg of pepstatin in 900 μL of 200 proof ethanol and 100 μL of glacial 
acetic acid, and dissolving 17 mg of PMSF in 1 mL of 200 proof ethanol.  A volume of 
50 μL, 100 μL, and 100 μL, respectively, of stock solutions, was added per 100 mL of 
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cell suspension.  Three variations of cell lysis were attempted to try and reduce protein 
degradation.  First was the freeze/thaw method.  Two samples, one with protease 
inhibitors and one without, were placed in liquid nitrogen and allowed to freeze.  Then 
the two samples were placed in a 37°C water bath to thaw.  This procedure was repeated 
two more times.  Two other samples were also frozen in the same manner, but allowed to 
thaw more slowly in a 0°C ice bath.  Another method involved the use of lysozyme.  One 
sample contained protease inhibitors and the other did not.  These samples were 
suspended in lysozyme lysis buffer (50 mM Tris-HCl (pH 7.2), 5% glycerol, and 1 mM 
dithiothreitol (DTT)), rather than the previously mentioned 20 mM Tris-HCl (pH 7.2) 
buffer.  The lysozyme was added to a final concentration of 300 μg/mL and allowed to 
incubate for approximately four hours at 4°C.  Finally, different methods of sonication 
were investigated as well.  Two samples contained the previously mentioned protease 
inhibitors, while one was suspended in 20 mM Tris-HCl (pH 7.2) buffer and the other 
was suspended in another lysis buffer (50 mM Tris-HCl (pH 7.2) and 5 mM DTT).  Two 
other samples were prepared in the two buffers, but without protease inhibitors.  These 
four samples were sonicated for 15 second intervals with 30 second rests, for a total of 
four times.  The samples were kept on ice during the entire process.  Another set of four 
samples, treated as previously mentioned, were sonicated for 10 second intervals with 30 
second rests for a total of ten times.  Finally, two samples, both in 20 mM Tris-HCl (pH 
7.2) buffer were treated in the original manner, one without protease inhibitors and one 




Protein Concentration for Crystallization Trials: 
A concentration calibration curve for the Bradford Assay was performed 
according to the manufacturer’s (Bio-Rad) instructions against known concentrations of 
bovine serum albumin (BSA).  This was done on a Beckman Coulter DU 530 UV/Vis 
Spectrophotometer at a wavelength of 595 nm.  Then, a 20 μL aliquot was combined with 
1 mL of Bradford Assay solution (at room temp) and was shaken vigorously in the 
cuvette.  A blank solution, containing only Bradford Assay, was placed into another 
cuvette.  The samples were incubated at room temperature for 10-15 minutes.  The blank 
was placed into the sample holder of the DU 530 and was analyzed.  The sample cuvette 
was then placed into the sample holder and the absorbance value was obtained.  This 
value was used to determine the concentration of protein in the solution by use of the 
previously derived calibration curve.  Once the initial concentration was determined, a 
final volume was calculated to concentrate the sample down to achieve the desired 
concentration of 10 mg/mL.  To concentrate the sample, the solution was placed into a 15 
mL Vivaspin tube with a 30,000 molecular weight cutoff (MWCO) and centrifuged 
(Beckman Coulter Allegra X-15R, 3050 rpm, 4°C) until the volume desired was shown 
within the tube’s graduations.  This solution was then put in a microcentrifuge tube, 
labeled, and placed in storage at 4°C. 
 
Crystallization: 
 Crystallization trials were carried out in Hampton VDX trays, which are modified 
24-well cell culture trays.  The hanging drop method was used with initial amounts of 
reservoir and protein solution in the drop being 2 μL each.  To set up a tray for 
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crystallization, the edges of the wells must be greased to allow for a closed system when 
sealed with a coverslip.  The grease was applied by way of a syringe.  Next, each reagent 
needed to create the reservoir solution is added one by one.  The total volume of the well 
solution used was 1 mL, so distilled water was added last to meet this volume 
requirement.  The tray is lightly shaken to allow for adequate mixing of all chemicals.  To 
prepare the crystallization drop, 2 μL of the reservoir solution is first pipetted onto a 
coverslip.  Then, 2 μL of the concentrated, purified protein solution is added and mixed 
into the reservoir drop.  The coverslip is then placed over the well and pressed down, so 
as to form a tight seal.  All 24 wells were prepared in a similar manner and the tray was 
set inside a cabinet to be isolated from sunlight.   
 
 A reservoir solution is typically made up of a precipitant (usually an organic 
compound) of which there can be more than one, a buffer, and possibly a salt.  To 
determine the identity and concentrations of reagents needed to crystallize the protein, 
two pre-made crystal screens were purchased from Hampton44, 45.  The protein solution 
was introduced to drops from the 98 different combinations of chemicals in the screens 
and sealed with a well solution containing 1 mL of the chemical combination.  The trays 
were checked periodically for crystal growth.  After several conditions were identified as 
possible candidates, more defined trials were performed.  The concentrations of the 
individual components, the pH of the buffer, the use of different salts, and temperature 
were altered to try to hone in on a good method for crystallization.  Several conditions 
were found to produce crystals.  The P3 protein crystallized quickly, usually within 24 




 Once crystals were formed, a test for X-ray diffraction was done.  The coverslip 
was taken from over the well and placed with the drop facing up.  The crystal mounting is 
performed with the aid of a stereomicroscope.  For room temperature data collection, the 
crystal is mounted into a 0.5 mm glass capillary.  The crystal is drawn into the capillary 
along with some of the drop solution.  Excess liquid is removed from around the crystal 
with a small wick created from filter paper.  The wet portion of the wick is cut with a 
razor and left in the capillary tube to supply moisture to the crystal after the capillary is 
sealed.  The ends of the capillary are cut with a glass cutting board and sealed with bee’s 
wax.  For data collection at cryo temperatures, a loop was used to lasso a crystal from the 
drop.  Once the crystal was seated, the loop was placed onto the goniometer head of the 
X-ray diffractometer (Bruker Microstar) under a nitrogen cryo stream (100 K; Oxford 
Cryosystems COBRA).  The power was set at 2.5 kW (45 kV and 55 mA).  The 
remaining steps were the same for both the room temperature and cryo-preserved 
crystals.  The crystal was then centered as best as possible within the center of the X-ray 
beam.  A camera focusing on the crystal gave streaming video to the computer monitor.  
The crystal could be spun in 90° angles and adjusted up and down and back and forth 
until it stayed within the centered area indicated on the computer screen.  This center 
corresponds to the center of the X-ray beam.  Then various modes for detection were set 
with the systems software (Proteum 2).  The detector was adjusted to a distance of 70 mm 
from the goniometer head (the sample holder).  The length of time could be adjusted to 
allow for better intensity of diffraction.  If no diffraction was observed, the crystal was 
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readjusted for additional collection or removed.  However, if diffraction was detected and 
to a decent resolution, further exposure of the crystal followed to allow for preliminary 
data to be collected.  Proteum 2 was used to create a collection scheme to expose the 
crystal to X-rays for several frames and at different angles.  After this was completed, 
manipulation of the data gave a preliminary space group.  If decent results were evident 
at this stage, even more exposure could be performed.  The crystal could then be exposed 
to more X-rays through a program executed by the computer program.  This usually 
resulted in hundreds of frames that could then be read by SAINT NT46 and XPREP47 to 
give better results.  This would give a better idea of the space group involved and the 
degree of certainty with which the results could be trusted. 
 
2.3 Results and Discussion  
 
Culture and Over-Expression of Protein P3: 
 In order for crystallographic studies to be done on Bam35 P3, it is important to 
have a large quantity of highly pure protein.  In order to obtain the required protein, it is 
important to have optimal growth conditions for the bacteria that are over-expressing the 
protein.  Thus, great interest was placed in finding the best media conditions for bacterial 
growth and protein expression so that optimal protein production could be achieved.  A 
pre-made LB broth, purchased through VWR, provided good protein expression, but it 
was costly and delivery was not guaranteed, so other methods were investigated.  Three 
batches of media, each containing yeast extract, tryptone, and sodium chloride (purchased 
as a pre-mixed composite from Amresco), were prepared and spiked with either 0%, 
0.1%, or 1% glucose.  All three batches were autoclaved and then used for culturing 
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bacteria under the same conditions.  After running SDS-PAGE gels to confirm the 
presence of P3 and approximating the protein amounts from the UV chromatograms 
obtained on the Bio-Rad DuoFlow (See Figure 2-5), it was determined that 0.1% glucose 
gave the best results (See Figure 2-6). 
 
 
Figure 2-5.  Full chromatogram of P3 run through the 5 mL GE Healthcare Hi-Trap SP column.  
The P3 peak occurs in the middle of the run, starting around 22 minutes and ending around 30 
minutes.  The other peaks in the chromatogram were analyzed on a SDS-PAGE gel and were found 
to not be P3.  The black line indicates the salt (Buffer B) as it was programmed to run.  The SP 
column is a cation exchange column, as purification is carried out using ion exchange 
chromatography.  All other chromatograms shown are analyzed in the same manner, but are zoomed 
into the peak of interest. 
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Figure 2-6.  Glucose comparison chromatogram overlay.  The peak corresponding to the 0.1% 
glucose concentration gave the highest absorbance reading of all three trials.  The 1% trial shows no 
peak, indicating that the concentration of glucose has caused the bacteria to multiply rapidly in the 
rich medium.  After the population could not be supported any longer, the bacteria began to die and 
the P3 protein was lost.   
 
Since the formulation of the Sigma media had been determined (yeast extract, 
tryptone, and sodium chloride filtered through a 0.2 μm filter, instead of being 
autoclaved), we wanted to compare these results with the VWR media, to see if similar 
results could be obtained.  Three batches of bacteria were cultured under the same 
conditions.  One batch was made with the VWR media, one was made with the Sigma 
media, and the last batch was the Amresco premixed formulation, which was spiked with 
0.1% glucose.  Due to bad weather interrupting the growing process, only initial results 
were available.  It was determined that the quantity of bacteria produced with the Sigma 
media gave equivalent results to the VWR media.  Using this knowledge, four batches of 
media were prepared.  Two of the batches contained the three components used in the 
 30
Sigma formulation.  One of these batches was autoclaved and the other was filtered 
through a 0.2 μm filter.  The other two batches contained the three components with the 
addition of 0.1% glucose.  Again, one batch was autoclaved and the other filtered.  The 
best results occurred with the batch that contained no glucose and was autoclaved (See 
Figures 2-7 – 2-13).  These results were not run in triplicate.  However, these optimal 
results have been repeated numerous times and the same results have been obtained. 
 
 
Figure 2-7.  SDS-PAGE gel analysis of P3 produced with no glucose and autoclaved media.  The first 
lane of the 15% gel corresponds to the molecular weight (MW) standard.  The next four lanes 
correspond to the flow through of the isolated protein and washes with 20 mM Tris-HCl pH 7.2 
through the Hi-Trap Q column.  The P3 protein is seen as the strongest band (second from the top) in 
the first three of the four lanes and can be seen very faintly in the fourth.  The sixth lane contains the 
1 M NaCl wash, which washes off any components still sticking to the column.  The last four lanes 
are the flow through collected from the Q column and the three washes with the Tris buffer onto the 
Hi-Trap SP column.  Notice that the P3 protein band is not evident, as it binds to the SP column. 
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Figure 2-8.  SDS-PAGE gel analysis of P3 produced with no glucose and filtered media.  Refer to 




Figure 2-9.  SDS-PAGE gel analysis of P3 produced with glucose and autoclaved media.  See Figure 




Figure 2-10.  SDS-PAGE gel analysis of P3 produced with glucose and filtered media.  See Figure 2-7 




Figure 2-11. SDS-PAGE gel analysis of P3 produced with no glucose and autoclaved and filtered 
media run on Bio-Rad DuoFlow.   This gel shows the results of the analysis of the SP column run on 
the Bio-Rad DuoFlow.  The first five lanes contain samples taken from five 1 mL culture tubes 
corresponding to the P3 protein as shown on the chromatogram for the autoclaved, glucose deficient 
conditions.  The last five lanes contain samples taken for the filtered, glucose deficient conditions.  
This gel shows that the autoclaved conditions gave a higher P3 production. 
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Figure 2-12.  SDS-PAGE gel analysis of P3 produced with glucose and autoclaved and filtered media 
run on Bio-Rad DuoFlow.   This gel shows the results of the analysis of the SP column run on the Bio-
Rad DuoFlow.  The first five lanes contain samples taken from five 1 mL culture tubes corresponding 
to the P3 protein as shown on the chromatogram for the autoclaved, glucose containing conditions.  
The last five lanes contain samples taken for the filtered, glucose containing conditions.  This gel 
shows that the P3 production in these two instances is fairly equal, but is less then the glucose 
deficient, autoclaved condition seen in Figure 2-11.   
 
Figure 2-13.  Chromatogram overlay of glucose/no glucose and autoclaved/filtered comparisons.  
This chromatogram overlay of the Bam35 P3 peak from the SP column run on the Bio-Rad DuoFlow 
from all four conditions confirms the SDS-PAGE analysis that the optimal condition for P3 
production occurred in the media containing no glucose and was autoclaved. 
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Isolation and Purification of Protein P3: 
Every SDS-PAGE gel of the purified protein showed several bands in addition to 
the expected position of the P3 protein.  Gel filtration was unable to remove any of the 
contaminants with the protein eluting as a single peak corresponding to the molecular 
weight expected for the P3 trimer (~120 kDa).  Since gel filtration did not seem to help 
with the purity of the protein and only resulted in some loss of protein quantity, this step 
was removed from future purification protocols.  It was decided to analyze the other 
bands present with MALDI-TOF, Matrix Assisted Laser Desorption /Ionization-Time of 
Flight, mass spectroscopy.  The bands were cut from the gels, dissolved, and trypsinized 
before analysis – a service provided by the Department of Biochemistry and Molecular 
Biology Core Facility.  It was discovered that one band, the highest molecular weight 
(around 70 kDa), was most likely oligopeptide-binding protein precursor from our E. coli 
that was co-eluting with our protein of interest.  However, the other bands were all 
Bam35 P3 that had been cleaved, though all were predicted as a hypothetical protein 
since Bam35 P3 is not annotated in the Mascot database (See Figures 2-14 – 2-19).  This 
led us to believe that during the isolation of the P3 from the bacterial host, the protein 
was being cleaved in multiple positions.   
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Figure 2-14.  SDS-PAGE gel reference for MALDI-TOF results.  Numbered bands from this SDS-
PAGE gel reference should be used to relate to MALDI-TOF results in Figures 2-15 to 2-19.  The P3 
protein was highly concentrated to bring out “contaminants” and there are other bands present 
along with the protein than the ones noted.  However, only the more evident bands were analyzed 
with MALDI-TOF.   
 
Figure 2-15.  MALDI-TOF results for band #1.  Scores of greater then 78 are considered significant.  
The high score here correlates with the band being oligopeptide-binding protein precursor from our 









Figure 2-17.  MALDI-TOF results for band #3.  The MALDI-TOF results confirm that it is 




Figure 2-18.  MALDI-TOF results for band #4.   The MALDI-TOF results confirm that it is 




Figure 2-19.   MALDI-TOF results for band #5.   The MALDI-TOF results confirm that it is 
hypothetical protein Bam35 P3. 
 
 
Since the mass spectrometric analysis showed that P3 was being cleaved at 
multiple positions, we thought that it might be proteases from the E. coli being released 
when the bacteria are broken apart during protein purification, even though the bacterial 
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host is specially designed to reduce proteases.  We decided to use protease inhibitors (PI) 
to see if this will eliminate the protein cleavage.  However, it was established that the 
addition of PI did nothing to improve the apparent protein degradation (See Figure 2-20). 
 
 
Figure 2-20.  SDS-PAGE gel analysis of P3 with PI added.  This is an SDS-PAGE gel analysis from 
samples taken from the SP column run on the Bio-Rad DuoFlow.  Protease inhibitors were spiked 
into the cultured bacteria before sonication.  The first lane contains the MW standard.  The next six 
lanes contain samples from the peak on the chromatogram corresponding to P3.  The last three lanes 
are taken from another peak which appeared at the end of the run.  This gel shows that there are still 
degradation bands present along with the P3 (indicated as the large bands in lanes 2-7), despite the 
PI addition.  Refer to Figure 2-14 for a reference gel with no PI added. 
 
 
Therefore, other methods of isolation from the bacterial host were performed to 
attempt a reduction in degradation.  The original method used sonication (two 1-minute 
sonications with an approximately five minute resting period on ice between them) to 
break open the cells and release the Bam35 P3 protein.  First, the freeze/thaw method was 
performed.  It was chosen because it is one of the more gentle isolation techniques, due to 
the lessened amount of stress on the bacteria.  After spiking two of the four samples with 
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PI and thawing at different temperatures, it was determined from the SDS-PAGE gels and 
the ion exchange chromatograms that this method did not seem to diminish the other 
Bam35 P3 bands present (See Figures 2-23).  Also, it was not adequate in releasing a 
decent amount of protein (See Figure 2-21).   
 
Figure 2-21.  Chromatogram overlay of freeze/thaw isolation methods.  The chromatogram overlay 
of all four analyses of the freeze/thaw methods shows that in relation to actual protein recovery, these 
methods are quite poor.  The thawing at 37°C gave the highest amount, which is not surprising.  It is 
surprising to note that the PI seem to reduce the amount of P3 protein recovered. 
 
 
Isolation by means of lysozyme was investigated.  This is another well known 
method of isolation that is used because it is more gentle than sonication. Again, this 
method showed small amounts of protein were isolated and no reduction in the other 
Bam35 P3 bands were achieved on the SDS-PAGE gels (See Figures 2-22 and 2-23).   
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Figure 2-22.  Chromatogram overlay of the lysozyme isolation method.  This lysozyme 
chromatogram overlay shows that the P3 peaks do not occur in the same places for the two analyses.  
There is a P3 production for the PI addition, but that peak occurs very early in the run.  As far as 
protein recovery, again this method is quite poor. 
 
 
While the two previously mentioned methods are considered to be gentler, it was 
evident that protein release was hindered and the gentler methods did not seem to inhibit 
protein degradation.  Different sonication times and repetitions were performed to see if 
these would produce less degradation and possibly even produce more protein.  A marked 
improvement was noted in released protein in the two new sonication timed trials (4 x 15 
secs and 10 x 10 secs) versus the previous method (2 x 1 min).  However, each of the 
three different variations showed no improvement or worsening of the protein 
degradation issue (See Figures 2-23 – 2-26).  Also, all trials performed, including the 
freeze/thaw and lysozyme methods, showed again that the addition of PI did nothing to 
improve on degradation.  It was noted from comparing protein amounts from the 




Figure 2-23.  SDS-PAGE gel of P3 sonicated 10 times for 10 seconds in lysis buffer with PI added.  
This gel is indicative of all SDS-PAGE gels analyzed for all isolation methods.  No method or PI 
addition was able to reduce or eliminate the degradation bands. 
 
 
Figure 2-24.  Chromatogram overlay of sonication method (4x15).  As far as protein recovery, this 
results in a mixed message.  However, it appears that the addition of PI in Tris buffer, as opposed to 




Figure 2-25.  Chromatogram overlay of sonication method (10x10).  This method showed that lysis 
buffer was preferred over Tris buffer.  This method gave the highest protein recovery, with the 




Figure 2-26.  Chromatogram overlay of sonication method (2x1).  Both analyses were carried out in 
Tris buffer.  Again, there is an indication of no PI giving the best protein recovery. 
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After being unsuccessful with finding the cause of the degradation bands, a search 
was done to try to find other explanations than the ones explored.  An article was located 
that described the boiling process in the preparation of the samples for the SDS-PAGE 
gels to be the root cause of degradation48.  This led to an investigation of various boiling 
times and temperatures.  Six different heating temperatures were investigated, as were 
three different heating times.  This led to eighteen separate samples which were analyzed 
with SDS-PAGE gels.  This analysis finally gave an answer to the cause of the 
degradation bands seen on the gels.  All three times taken at 60°C showed no degradation 
bands.  These bands could be seen faintly at all three heating times for 70°C and 80°C.  
The analysis of the samples taken at 90°C, 95°C, and 100°C showed a profound and 
almost equal degradation of the protein sample (See Figure 2-27 and 2-28).  This means 
that the protein sample itself is extremely pure and is not degraded.  The apparent 
cleavage occurs during sample preparation. 
 
Even after obtaining pure P3 protein, there were problems noted with its stability.  
At lower concentrations, it would last for about a month at 4°C before “crashing out”, i.e. 
precipitate out as a white solid.  When the protein was stored at higher concentrations, the 
length of time was shortened to about two weeks.  It was found that the addition of 2% 
ethylene glycol to the Tris buffer lengthened the P3 solution lifetime from two weeks to 
three.  Therefore, it became necessary to only make small amounts of P3 protein 
solutions at a time, but more frequently.  This instability is in contrast to the PRD1 P3 




Figure 2-27.  SDS-PAGE analysis of different heating times at 60, 70, and 80°C.  The first lane 
contains the MW standard.  Lanes 2-4 contain samples heated at 60°C for 2, 5, and 10 minutes, 
respectively.   Lanes 5-7 contain samples heated at 70°C for the three trial times.  The last three lanes 
are the samples heated at 80°C for the three trial times.  The 60°C samples show no degradation 
bands.  The 70°C samples show the beginnings of the cleaved bands and they can be seen more 
readily in the 80°C sample lanes.  This indicates that the P3 purified solution is indeed pure and free 




Figure 2-28.  SDS-PAGE analysis of different heating times at 90, 95, and 100°C.  The first lane 
contains the MW standard.  Lanes 2-4 contain samples heated at 90°C for 2, 5, and 10 minutes, 
respectively.   Lanes 5-7 contain samples heated at 95°C at all three trial times.  The last three lanes 
are the samples heated at 100°C for all three trial times.  Degradation bands are very evident in all 
samples viewed on this gel. 
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The increased stability for PRD1 is indicated to be from its host preference, thus allowing 
it to exist in more hostile environments27. 
 
Crystallization: 
We used previously known crystallization conditions, discovered by our 
collaborators, in our beginning stages of crystallization trials for Bam35 P3 (given at the 
beginning of the next paragraph).  In the initial stages of the crystallization trials, 7 
mg/mL protein concentration was used.  This produced crystals that were very thin and 
shaped like plates (see Figure 2-29).  A lower concentration, 5 mg/mL, was tried to see if 
crystal shape and quality could be improved.  It was hypothesized that lower 
concentrations might reduce the amount of nucleation leading to fewer, more singular 
crystals.  However, very poor results were noted.  There was mostly precipitate in the 
hanging drop instead of crystals.  A higher concentration was attempted by increasing it 
to 10 mg/mL.  The thinking here was that the crystals were being starved of material and 
thus not continuing to form in the same direction, thus leading to twinning.  However, if 
the concentration was increased, the nucleation could continue in the same order 
producing singular crystals.  Fewer crystals were produced than with the 7 mg/mL 
concentration, and there was a marked improvement in crystal shape.   The crystals were 
much thicker and in the shape of a 3-D prism (See Figure 2-30).    
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Figure 2-29.  Crystal formed with 7 mg/mL protein concentration.  Notice the thinness of the crystals.  
(There are actually three crystals viewed here.  Two stacked on top of each other and one protruding 
to the right.) 
 
 
Figure 2-30.   Crystal formed with 10 mg/mL protein concentration.  Notice that these are rod shaped 
and are 3-dimensional, unlike those seen in Figure 2-29. 
 
 
 Two initial conditions showed promise in the formation of P3 crystals: 8.5% 
polyethylene glycol (PEG) 8K, 50 mM sodium acetate, 50 mM potassium phosphate (pH 
7.0); and 8.0% PEG 8K, 55 mM sodium acetate, and 25 mM sodium cacodylate (pH 7.0).  
With these conditions not only are crystals formed, but they appear rapidly, usually 
within 24 hours or less.  After performing trials where concentrations of all species 
present were manipulated and pH ranges were adjusted, I found the second condition to 
be best.  One problem that occurred from the rapid formation of the P3 crystals was a 
showering of crystals.  In other words, a great number of crystals formed, but they were 
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too small to analyze.  Also, as mentioned earlier, they were very thin and fragile.  
Additionally, the crystals also degraded soon after forming.  It was proposed that slowing 
down the nucleation process would allow for better crystal formation.  Therefore, trials 
were performed at cooler temperatures (4°C and 11°C) than room temperature.  
However, these trials never produced crystals, instead eventually precipitation occurred 
within the drop. 
  
 It was decided that a sparse matrix crystal screen would be done to see if there 
were any other possible conditions for crystal formation.  The crystal screens were 
purchased from Hampton Research and contain 48 to 50 conditions that have been taken 
from publications as popular and productive crystallization conditions44, 45.  After 
performing this trial, I did discover a couple of new conditions that formed crystals.  
After further work on these only one condition ended up working well, 10% PEG 8K, 8% 
ethylene glycol (EG), and 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES) (pH 7.5).  It was decided to screen this condition with different salts to see if 
crystallization could be enhanced.  Of the ones tried, two worked well, sodium chloride 
and sodium citrate.  The condition that worked well with the sodium chloride was 10% 
PEG 8K, 8% EG, 80 mM HEPES (pH 8.0), 80 mM NaCl.  With the addition of sodium 
citrate, the condition that worked well was 10% PEG 8K, 8% EG, 80 mM HEPES (pH 
8.0), 10 mM sodium citrate.  Using these two conditions, thicker crystal were produced 
than had been seen previously.  However, when in trying to diffract these crystals, the 
diffraction pattern suggested that they were twinned.  A common type of crystal twinning 
occurs when two different crystals share some of the same crystal lattice points in an 
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equal manner. The result is an intergrowth of the two crystals in a variety of specific 
arrangements.  Twinning can also occur when the plates lay down on top of each other, 
but are not adequately aligned.  The latter was the most likely cause of the twinning 
observed for P3. 
 
The best condition that repeatedly gave good crystal formation seemed to be 8.0% 
PEG 8K, 55 mM sodium acetate, and 25 mM sodium cacodylate (pH 7.0).  We were able 
to collect diffraction data on these crystals, as well as those from some of the other 
conditions.   
 
Currently, the Index Screen49-51 (96 conditions), purchased from Hampton 
Research, is being used to try and determine new and better crystallization conditions.  
This screen is a combination of several screens and uses classic, contemporary, and new 
regeants49-51.  Currently, there have been several conditions which have caused 
crystallization to occur.  Two of the best are 12% PEG 3350, 0.1 M HEPES (pH 7.5), 
0.005 M CoCl2, 0.005 M NiCl2, 0.005 M CdCl2, 0.005 M MgCl2 and 10% PEG MME 
5000, 0.1 M HEPES (pH 7), 5% Tacsimate (pH 7).  Additional reagents are being 
purchased and further trials will continue in this area. 
  
X-ray Diffraction: 
 Early on a rod shaped crystal, which formed from the sodium cacodylate 
conditions, was prepared for analysis with the X-ray diffractometer.  The crystal, along 
with some of the mother liquor, was placed into a capillary tube, sealed with bee’s wax, 
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aligned into the X-ray beam, and run at room temperature on the diffractometer.  It 
diffracted to a moderate resolution of 3.5 Å.  The space group was determined to be 
orthorhombic (P212121).  The unit cell was determined to have sides of a = 128.04 Å, b = 
146.44 Å, and c = 168.42 Å.  Due to the space group determined, this makes all angles 
(α, β, and γ) 90°.  However, because the data was taken at room temperature and the 
crystal was not protected from the intense radiation, the crystal deteriorated before 
complete data could be collected.  It was at this point that it was decided that cryo 
temperatures were needed to preserve any future crystals for analysis.  Cryo-preservation 
would allow for the crystal to be stabilized and to be protected from the radiation, which 
dramatically extends its lifetime (essentially being immortal on laboratory X-ray 
sources).  This allows for longer data collection times. 
 
 After the nitrogen cryo stream was in place, crystals were looped up, placed under 
the nitrogen stream, and analyzed initially to see if any diffraction could be detected.  
Before being placed in the nitrogen stream, the crystals were introduced to a cryo-
preservant, usually the mother liquor with a small percentage (~10%) of ethylene glycol 
added.  This allows for the formation of vitreous ice, not crystalline ice, which will not 
interfere with diffraction.  If decent diffraction was achieved (i.e. diffraction out to at 
least 3 Å, no obvious twinning, good intensity), then the crystal was further analyzed to 
obtain data for indexing.  Indexing gives preliminary information on the crystal’s space 
group and unit cell.  If this information is adequate, then further analysis can be done to 
determine more about the crystal structure in detail. 
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 A crystal which was grown with 10% PEG 8K, 8% EG, 80 mM HEPES pH 8.0, 
and 80 mM NaCl was analyzed.  Diffraction was sufficient and a run was performed to 
allow for indexing.  This indicated that the sides were a = 67.658 Å, b = 121.072 Å, and c 
= 123.851 Å.  The angles are α = 112.026°, β = 104.195°, and γ = 103.529°.  The space 
group was determined as triclinic P1.  After indexing, the prediction of where diffraction 
spots should be located did not identify all the spots that were observed.  The confidence 
in this unit cell determination was not high.  We were unable to collect further data from 
this crystal and another crystal from the same well did not show diffraction.  Another 
well was looked at, with a different set of conditions, 10% PEG 8K, 8% EG, 20 mM 
HEPES pH 8.0, and 10 mM NaCl.  A crystal from this well gave diffraction and was able 
to be indexed; however, again with not much confidence.  The information determined 
from it gave side lengths of a = 65.51 Å, b = 123.4 Å, and c = 124.3 Å, angles of α = 
119.75°, β = 101.8°, and γ = 98.92°, and a triclinic P1 space group.  Further analysis of 
this crystal was initiated, but was unable to be completed due to low intensity of the 
spots.  Later, a crystal that was formed from 10% PEG 8K, 8% EG, 80 mM HEPES pH 
8.0, and 80 mM NaCl was analyzed again.  However, the drop contained 4 μL of protein 
solution, rather than the standard 2 μL, and the well contribution was left at 2 μL.  The 
diffraction test indicated that the crystal was twinned, but further analysis was conducted 
anyway.  Indexing showed a = 213.5 Å, b = 124.1 Å, and c = 299.9 Å side lengths, α = 
90°, β = 113.99°, and γ = 90° angles, and monoclinic C for the space group.  Another 
crystal grown with 10% PEG 8K, 8% EG, 80 mM HEPES pH 8, 10 mM NaCl gave 
indexing information of a = 68.6 Å, b = 125.7 Å, and c = 206.4 Å and α = β = γ = 90° 
with a space group of orthorhombic P.  We have high confidence in the unit cell and 
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space group determination of the capillary mounted crystal.  However, there is much less 
confidence in the determinations from all the other crystals.  This is due to the fact that 
the predicted locations of the diffraction patterns did not cover all the collected 
diffraction spots.  
 
I was finally able to collect information about two crystals, besides the earlier 
capillary mounted crystal, beyond the indexing stage.  This included using two programs 
to further analyze the crystal data, SAINT-NT and XPREP.  SAINT-NT46 is a data 
processing program that converts raw crystallographic frame data into integrated intensity 
sets with standard deviations, direction cosines, and XYZ centroids.  It has the ability to 
do spatial correction in the frames, background subtraction, and error analysis, among 
others.  XPREP47 is a program that performs an analysis and manipulation of intensity 
data.  The operations include space group determinations, intensity statistics, scaling and 
merging of different data sets, derivation and filtering of anomalous differences, as well 
as several others.  It can be used to determine a reduced primitive unit cell, known as the 
Niggli cell.  One of the crystals, produced with 10% PEG 8K, 8% EG, 80 mM HEPES 
pH 8.0, and 10 mM sodium citrate, was indicated by XPREP as having a = 125.2 Å, b = 
216.7 Å, and c = 161 Å and α = γ = 90°, β = 100.77.  Monoclinic C was determined to be 
the space group.  The other crystal, which was formed by 10% PEG 8K, 8% EG, 80 mM 
HEPES pH 8.0, and 80 mM NaCl, gave indexing in XPREP as a = 69.085 Å, b = 121.554 
Å, and c = 122.545 Å, α = 60.48°, β = 76.60°, and γ = 81.53°, and triclinic P1 for the 
space group.   
 
 52
The Matthew’s coefficient, Vm, allows for the determination of the number of 
molecules within the asymmetric unit by using a simple calculation. 
Vm = volume of unit cell / (MW * A * X) 
MW= molecular weight in daltons 
A= the number of asymmetric units in the unit cell (the number of 
symmetry operators in the predicted space group) 
X= the number of molecules in the asymmetric unit   
The most probable values of X are those that give a Vm output that falls within the 
expected range of 1.68 to 3.53 Å3/Dalton.  The expected solvent content, calculated as 1-
1.23/Vm, should lie in the range of 27-65%52.  However, there certainly are exceptions to 
these ranges. 
 
 Using Matthew’s coefficient, it was determined that for the capillary mounted 
crystal, the Vm = 3.31 Å3/Dalton and 63% solvent for three trimers within the 
asymmetric unit.   Repeating the calculation for two trimers, Vm = 2.48 Å3/Dalton and 
50% solvent.  Three trimers within the asymmetric unit seems probable, but two 
molecules can not be ruled out.  The monoclinic C space group had a Vm = 3.00 
Å3/Dalton and 59% solvent for three trimers within the asymmetric unit.  Two trimers 
gives a Vm = 4.50 Å3/Dalton and 73% solvent.  Therefore, this crystal most likely has 
three trimers within each asymmetric unit.  The second crystal, space group of triclinic 
P1, gave a Vm = 3.65 Å3/Dalton and 66% solvent for two trimers.  A second calculation 
with three trimers gave a Vm = 2.44 Å3/Dalton and 50% solvent content.  Again, three 
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 I have been able to obtain a highly pure protein solution in adequate quantities, 
due to several findings.  First, a reproducible, reliable medium was needed to produce 
large amounts of bacteria, which would in turn produce sufficient quantities of P3 
protein.  Through the course of several experiments, this was determined to be the 
combination of the individual components, tryptone, yeast extract, and sodium chloride, 
with no glucose addition needed and the solution needed to be autoclaved.  Protein 
degradation appeared to be a problem in the purified protein solution.  Attempts to 
correct this situation proved fruitless.  However, the finding that indeed the problem was 
due to SDS-PAGE preparation and not in the solution itself was very exhilarating.  Once 
we knew for sure that we were producing an extremely pure protein solution, all efforts 
could be placed on crystal production.  So far, crystal production has been both 
encouraging and frustrating.  Even in initial crystallization trials, crystals have been 
produced and sometimes in large quantities.  However, there have been obstacles that we 
have been working to overcome.  Early crystals proved to be numerous, but very small.  
Even after conditions were improved to increase crystal size, they were too thin and 
produced very weak diffraction.  Conditions were further improved to produce thicker 
crystals, but these proved to be twinned.  The small amount of diffraction data has not 
been sufficient for further structure analysis.  Current work with metal additions to 
crystallization conditions is proving to be quite promising.  Weak diffraction was 
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detected in crystals taken from the crystal screen (i.e. have not been optimized), but was 
detected at fairly high resolution, around 3 Å.  Continued work in optimizing these 
conditions or in determining other beneficial conditions will certainly lead to the final 









 The discussion up to now has focused on structural studies of the major coat 
protein of Bam35 and related viruses.  A major reason to examine the major coat protein 
is due to the fact that it is the largest part of the virion.  However, additional valuable 
information could be acquired by investigating other viral structures for comparison 
purposes.  One area that we have begun studying is the genome packaging machinery of 
PRD1.  Bam35 and PRD1 both are suspected of having 11 regular vertices and one 
special vertex, used for packaging.  One of the proteins making up this vertex, P9, has 
been known for years and if it is absent, empty capsids are formed.  P9 functions as an 
ATPase and is involved in the active packaging of the genome.  Though the knowledge 
of P9 has been around for quite some time, the unique vertex is a relatively new 
discovery only recently confirmed with immunogold labeling and mutational studies25, 53 
and warrants further investigation.  As has been previously noted, much is now known 
about PRD1’s structural, genetic, and biochemical properties.  However, the special 
vertex has still not been visualized.  This is due to the fact that previous X-ray 
crystallography and image reconstructions from cryo-EM for PRD1 used icosahedral 
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averaging for the electron densities, which would obscure any proteins not obeying the 
icosahedral symmetry23.  This chapter looks at PRD1 and trying to isolate and crystallize 
one of the proteins making up the special vertex, P6, which was chosen due its ability to 
be over-expressed and its solubility.  P9 is being cloned by our collaborator for future 
structural studies. 
 
 This special vertex of PRD1 is involved in genome packaging into the empty 
capsids and is comprised of four individual proteins: P6, a minor structural capsid 
protein; P9, the packaging ATPase; and the small membrane proteins P20 and P22.  
Though currently the exact role of P6 is undetermined, it has been found to play an 
important role in the makeup of the special vertex.  A study has been performed using 
mutants that lacked the P20 or P22 membrane proteins.  It was found that in this case the 
mutant lacked the P6 protein as well.  In addition, it was noted that with the lack of P6 
also came the lack of P9.  This suggests that the membrane proteins are interacting via 
protein-protein interactions with P6, which then is associated with P9.  This also leads to 
the conclusion that this is indeed a unique, portal vertex for PRD1 and contains all the 
proteins necessary for DNA packaging and preservation within the particle.  This vertex 
also extends to the internal membrane, allowing for access to the genome of the phage25.  
Another study has investigated the membrane-associated protein P1654.  When the PRD1 
virion was determined by X-ray crystallography23, P16 was shown to be located beneath 
the other eleven vertices.  When mutations are introduced that eliminate P16, the virion is 
not able to correctly assemble the spike complex (located at the other eleven vertices) 
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needed for infectivity, but the packaging complex is correctly assembled, further 
supporting the idea that there is a unique vertex.  
 
 It has been suggested that P6 plays a major role in DNA packaging.  A mutant 
form of PRD1, free of any P6, has shown a severe deficit in the packaging of the phage 
DNA55.  Viral genes, which code for similar protein functioning, occur in close vicinity 
on their genome.  Gene VI codes for P6 and is located in front of gene IX, which codes 
for the known packaging ATPase P955.  This close genomic relationship therefore 
insinuates a close operational relationship. 
 
 A sequence alignment was performed with CLUSTAL X30 to compare the two P6 
proteins from Bam35 and PRD1.  This information was then displayed with GeneDoc56 
and the two were determined to have 17% identity and 32% similarity (See Figure 3-1).  
These two percentages correspond very closely to the relationship of these two 
bacteriophages in respect to their P3 sequences; although, the P6 sequences could not be 
grounded on the basis of structure as the P3 sequences have.  Structures of these two 
proteins are needed to confirm a similar fold.  The ATPases for PRD1 and Bam35, along 
with several members of the proposed lineage, have also previously been compared.  
They show a similarity in the Walker A and Walker B motifs, which are characteristic 
ATP binding sequences, and show a unique motif characteristic to this group of viruses, 
labeled the P9-specific motif57.  Thus indicating that similarity in structure extends 




Figure 3-1.  P6 sequence comparison for Bam35 and PRD1.  The sequence alignment was done with 
CLUSTAL X and displayed with GeneDoc.  The blue areas represent identity (17%) and the pink 
areas represent similarity (32%).  
 
 The tailed bacteriophages have an obvious special vertex, but it was thought that 
most dsDNA eukaryotic viruses did not.  It has been discovered that there is a unique 
vertex in Herpes simplex virus, HSV-1, which is a dsDNA virus infecting higher 
organisms25.  DNA packaging is thought to be one of the components of the viral “self”, 
resistant to evolutionary modification.  Therefore, it is of interest to extend our 
knowledge of viral protein coats, and their apparent similarities, and branch out to other 
structural properties, such as this special vertex.  Could adenovirus, PBCV-1, PRD1, 
Bam35, and the other proposed members of this lineage also show familial relationships 
in this area as well?  Sequence alignments with the ATPases from these viruses have 
shown the Walker A, Walker B, and P9-specific motif57 signatures in all of them.  
Extensive research has been performed on the special vertex of HSV-158 and tailed 
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bacteriophages and strong similarities have been observed.  However, these two show no 
structural similarity, other than possession of dsDNA genomes, with our proposed 
lineage.  If the virus is prevented from packaging its DNA, this will hinder its ability to 
infect a host, thus preventing viral disease.  If it is shown that there is a conservation of 
structure and function with this special vertex, a generalized mechanism could be 
discovered which could prevent its function and thus infectivity among any member of 
this virus lineage.  This thesis is attempting to begin to put together the pieces of the 
unique vertex of PRD1.  Because P6 currently remains a mystery as to its structure and 
true function, it was decided to try and crystallize and determine the structure of this 
protein.    
 
3.2 Research Design 
 
 
Bacteria Growth and Protein Over-Expression: 
 
For the growth of the PRD1 P6 protein, E. coli strain HMS174 (DE3) (pNS62) 
was used with the cloning vector being pJJ2 containing gene VI from PRD1 that was 
developed by our collaborator Dr. Jaana Bamford (University of Jyväskylä, Finland).  A 
bacterial colony was mailed as a stab agar culture.  A small amount was looped and 
spread onto an agar plate containing 50 μg/mL of ampicillin.  A single colony was 
selected and placed in 2 mL of LB media.  A glycerol stock was created by mixing the 2 
mL aliquot with an equal volume of 70:30 LB media/glycerol.  The mixture was 
vortexed, to ensure proper dispersion of the glycerol.  This was dispensed into 1 mL 
aliquots and stored at -80°C.  For additional bacterial growth for protein expression, a 
small amount was taken from the frozen stock solution and streaked on a Petri dish 
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containing agar and 50 μg/mL ampicillin.  This dish was then incubated at 37°C for 24 
hours.   
 
A colony was then picked and placed into a 100 mL baffled bottom Nalgene 
flask.  This flask contained 20 mL of Luria broth spiked with 150 μg/mL of ampicillin.  
The flask, as well as all others in the growing process, was capped and the cap was 
opened a quarter of a turn to allow for adequate oxygenation.  This was then placed in the 
Barnstead International Max Q 5000 incubator/shaker and incubated overnight at 28°C 
and 200 rpm.  The next day, the overnight culture was placed into a 1 L baffled bottom 
Nalgene or glass flask containing 480 mL of Luria broth spiked with 150 μg/mL of 
ampicillin.  This was allowed to incubate at 28°C and 200 rpm until proper optical 
density was reached (OD600 ≈ 0.8).   
 
IPTG (100 μM) was then added to induce the recombinant protein expression.  
The temperature and shaking were held constant at 28°C and 200 rpm overnight.  The 
cells were pelleted (Beckman Coulter Allegra X-15R, 4500 rpm, 30 min, 4°C), equally 
distributed between two 50 ml conical tip tubes, and each was re-suspended in 
approximately 10 mL of 20 mM Tris-HCl (pH 7.2).        
 
 
Purification of Protein: 
 
The cells were sonicated using a Branson Sonifier 150 set at level three.  The 
sample was sonicated for 15 seconds and allowed to rest on ice for 30 seconds before 
additional sonication.  This procedure was repeated three more times.  The cell debris 
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was centrifuged (Beckman Coulter Allegra X-15R, 4500 rpm, 40 min, 4°C) and the 
supernatant was decanted into a 15 ml conical vial tube.  A sample was taken for SDS-
PAGE.  The supernatant was further clarified by centrifugation (Beckman Coulter 
Allegra X-15R, 4500 rpm, 2-17 hr, 4°C) and a sample was taken for SDS-PAGE.   
 
The protein solution was then subjected to a salt cut using ammonium sulfate.  
Proteins will precipitate at varying concentrations of ammonium sulfate.  First, a pre-cut 
was done with 22% ammonium sulfate.  This was done by adding the necessary amount 
of grams to the given volume very slowly over a period of several minutes with vigorous 
stirring at room temperature.  After all of the ammonium sulfate had dissolved, the 
solution was allowed to stir for ten minutes.  At this point, the solution was centrifuged 
(Beckman Coulter Allegra X-15R, 4500 rpm, 15 min, 4°C) and decanted into a new 15 
ml conical vial.  Next, the ammonium sulfate was adjusted to 26% and stirred at room 
temperature for 10 minutes.  This concentration had been shown to precipitate PRD1 P6.  
The protein precipitation was pelleted as before and the solution decanted.  Samples of 
the supernatant and pellet were taken both times for SDS-PAGE.  The second precipitate 
was dissolved in 20 mM piperazine (pH 5.5). 
 
Next, a 5 mL Pharmacia HiTrap Q cation column was used.  The column was 
equilibrated by applying 25 mL of 20 mM piperazine (pH 5.5) with a syringe into the 
column.  The sample was applied in the same way.  This column was then placed onto 
the BioLogic DuoFlow system.  The buffers used were 40 mM piperazine (pH 5.5), 40 
mM piperazine (pH 5.5)/600 mM NaCl, and de-ionized water.  All buffers were degassed 
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prior to placing them into the system.  The program was set to collect 1 mL fractions and 
run at pH 5.5 during the course of the run.  First, an isocratic flow was used with 0% salt 
for a volume of 5 mL at 1 mL/min.  Next, was a linear gradient of 33-100% (99 mM – 
300 mM) salt which ran for a volume of 30 mL at 1 mL/min.  A final wash of the column 
came with an isocratic flow of 0% salt for 10 mL at 1 mL/min.  Fractions were taken, 
from the indicated collected tubes corresponding with the peak(s) on the chromatogram, 
for SDS-PAGE.  Desired fractions were combined based on the findings of the SDS-
PAGE gel. 
 
A 15 mL Vivaspin concentrator tube (10,000 MWCO) was used to aid in buffer 
exchange from 20 mM piperazine (pH 5.5) to 20 mM Tris-HCl (pH 7.2) in the centrifuge 
(Beckman Coulter Allegra X-15R, 3050 rpm, 4°C) and ran until the solution was below a 
volume of 1 mL. 
 
The concentrated solution was introduced into the 1 mL sample loop of the Bio-
Rad DuoFlow.  A gel filtration column was set up to analyze the solution.  The buffers 
used were 40 mM Tris base, 40 mM Tris-HCl, 2 M NaCl, and de-ionized water, all 
previously de-gassed.  Fractions of 1 mL were collected during the run, and the Tris-
buffer was maintained at a pH of 7.2.  An isocratic flow with 8% (80 mM) salt was used 
for 1 mL at a rate of 0.5 mL/min.  This was followed by the injection of the sample from 
the loop for 2 mL at 0.5 mL/min.  Another isocratic flow followed for 20 mL at 8% salt 
concentration at 0.5 mL/min.  Fractions were taken from the indicated collected tubes 
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corresponding with the peak(s) on the chromatogram for SDS-PAGE.  Desired fractions 
were combined based on the findings of the SDS-PAGE gel. 
 
A concentration calibration curve of the Bradford Assay against BSA was 
performed according to the manufacturer’s (Bio-Rad) instructions.  This was done on a 
Beckman Coulter DU 530 UV/Vis Spectrophotometer at a wavelength of 595 nm.  Then 
a 20 μL aliquot of the purified PRD1 P6 protein was combined with 1 mL of Bradford 
Assay solution (at room temp) and was shaken vigorously in the cuvette.  A blank 
solution, containing only Bradford Assay solution, was placed into another cuvette.  The 
blank was placed into the sample holder of the DU 530 and was read.  The sample 
cuvette was then placed into the sample holder and the absorbance value was obtained.  
This value was used to determine the concentration of protein in the solution by use of 
the previously derived calibration curve.  Once the initial concentration was determined, 
a final volume was calculated to concentrate the sample down to achieve the desired 
concentration of 7 mg/mL.  To concentrate the sample, the solution was placed into a 15 
mL Vivaspin tube and centrifuged (Beckman Coulter Allegra X-15R, 3050 rpm, 4°C) 
until the volume desired was shown with the tube’s graduations.  This solution was then 





 Crystallization was carried out in Hampton Research VDX trays, which are 
modified 24-well cell culture trays.  The hanging drop method was used with initial 
amounts of reservoir and protein solution in the drop being 2 μL each.  To set up a tray 
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for crystallization, the edges of the wells must be greased to allow for a closed system 
when sealed with a coverslip.  The grease was applied by way of a syringe.  Next, each 
reagent needed to create the reservoir solution is added one by one.  The total volume of 
the well solution needed was 1 mL, so distilled water was added last to meet this volume 
requirement.  The tray is lightly shaken to allow for adequate mixing of all chemicals.  
Then, 2 μL of the reservoir solution is pipetted onto a plastic coverslip.  Then, 2 μL of the 
concentrated, purified protein solution is pipetted and mixed into the reservoir drop.  The 
coverslip is then placed over the well and pressed down, so as to form a tight seal.  All 24 
wells were treated in the same manner, though each contained different quantities and 
identities of solutions, and the tray was set inside a cabinet to be isolated from sunlight. 
 
 A reservoir solution is typically made up of a precipitant (usually an organic 
compound) of which there can be more than one, a buffer, and possibly a salt.  To 
determine the identity and concentrations of reagents needed to crystallize the protein, 
two pre-made crystal screens were purchased from Hampton44, 45.  The protein solution 
was introduced to drops of 98 different combinations of chemicals and checked 
periodically for crystal growth.  Several different conditions were found to produce 
crystals.  However, before more trials could be performed, MALDI-TOF results showed 
that we did not have the P6 protein present.  There were eight bands analyzed with mass 
spectrometry, though some were duplicates from two separate gels.  This led to a 





3.3 Results and Discussion  
 
 
Purification and Isolation of protein: 
 
 The P6 protein has a molecular weight of 17573.38 daltons.  When the SDS-
PAGE gels were run after protein purification from the Hi-Trap Q column and the gel 
filtration column, the gels both showed a band in the range of the expected molecular 
weight.  However, this band was very light, indicating that hardly any protein was 
present.  Another band appeared at approximately 34-35 kDa, which could indicate a 
dimer of P6.  Even more interesting, a comparatively enormously intense band appeared 
at approximately 70 kDa.  This could indicate a tetramer of our P6 protein.  Several 
fainter bands appeared on the gels, but these three bands mentioned seemed to be the 
main proteins present (see Figures 3-2 and 3-3).  If these bands were related to P6, it 
would appear that the P6 protein solution was much more pure than the Bam35 P3 
solution had been in the early stages before identification of the protein cleavage caused 
by the sample preparation for SDS-PAGE analysis.  However, if there really was a 
presence of a monomer, dimer, and tetramer, especially a tetramer in the amounts 
indicated, there might be problems in using this solution to induce crystallization.  
Additionally, this was an SDS-PAGE gel where the protein is run in a denatured state.  
An SDS-PAGE running buffer is added that contains SDS, which helps denature proteins, 
and 2-mercaptoethanol that would disrupt any disulfide bonds, even though PRD1 P6 
does not contain any cysteine residues.  The protein solution with the SDS-PAGE 
running buffer is boiled for 10 minutes to further denature the protein.  We should expect 
to see the PRD1 P6 protein band corresponding to about 17.5 kDa on the gel, but the 
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previously run gels of purified protein from both intact viruses and recombinant proteins 
run around 37 kDa55. 
 
 
Figure 3-2. SDS-PAGE gel analysis of PRD1 P6.  The first lane is a sampling of the pellet as it was re-
suspended in 20 mM Tris-HCl pH 7.2, before it was purified.  The second lane contains the Q column 
flow through (note in this case P6 does not show on the gel as it is stuck on the column).  The third 
lane contains the MW standard.  All remaining lanes correspond to samples taken from the gel 
filtration analysis performed in the Bio-Rad DuoFlow.  Lanes 4-7 contain the peak thought to be P6 
and the remaining lanes are from a second peak that appeared at the end of the run.   
 
 
It was necessary to find out for sure if these three bands obtained from our 
purified sample really indicated three different forms of P6 or if they are bacterial 
proteins.  To do this, MADLI-TOF mass spectrometry was used on the trypsinized bands 
cut from the gels.  The results from the spectrometric analysis told a much different story 
than what we had expected.  None of the bands were associated with PRD1, much less 
the P6 protein.  The analysis showed that though the scores were too low to be considered 




Figure 3-3.   SDS-PAGE analysis of P6 on the Hi-Trap Q column run on the Bio-Rad DuoFlow.  The 




produced in.  The other samples proved to be inconclusive.  We then needed to find out 
why our protein was not being expressed. 
 
Crystallization: 
 All crystallization trials were performed before we knew the true identity of our 
protein solution.  Hampton crystal screen 1 & 244, 45 indicated five different conditions in 
which the protein solution formed small crystals.  One condition contained two different 
PEG components.  The other four all were comprised of a different organic precipitant 
and salt, but all contained 0.1 M Tris (pH 8.5).  Further trials were delayed until the 
identity of the bands from the mass spectrometric results was obtained.  After learning 







 A highly pure protein solution is needed to obtain favorable and reproducible 
crystals.  This has been achieved through several important discoveries.  First, the most 
ideal media conditions were obtained through several experiments.  We were able to 
ascertain that combining the individual components (tryptone, yeast extract, and sodium 
chloride) without the presence of glucose and autoclaving the resultant media solution 
gave the best bacterial growth, thus Bam35 P3 production.  While there were initial fears 
of protein degradation in our working sample, it was determined that indeed this was not 
the case.  This effort took much trial and error to obtain, but the end result has shown to 
be quite rewarding.  The protein solution that is obtained for the purification of Bam35 
P3 is not just mostly pure, but instead extremely pure.  This leads into crystal production 
that is definitely P3 and not a mixture of other proteins.  These results have been verified 
by the MALDI-TOF mass spectrometric analysis and the SDS-PAGE gels (with adequate 
heating times).  Crystals have been obtained from these pure protein solutions.  Crystal 
production has been achieved with great regularity, but with many problems encountered.  
In some cases they are too small to analyze and will even be present in dozens or 
hundreds in the drop.  In other cases they are larger in size, but are too thin to diffract 
with much intensity.  There have been some crystals that are larger 
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and more 3-dimensional, but they are usually twinned or show no or weak diffraction at 
low resolution.  Trials are still being performed and will need to be expanded upon in the 
future to try and produce better crystals.  Current work with divalent metal chloride 
additions in crystallization solutions has shown some promising preliminary results, 
meaning that the crystals have a nice shape and have shown weak diffraction, but to 
higher resolution (around 3 Ǻ).  Work in this area will continue.  Finding the right 
crystallization conditions is all that stands in the way currently of obtaining a visualized 
structure of Bam35’s capsid protein, P3. 
 
 Initial work with PRD1 P6 was slow and discouraging.  However, with recent 
progress in expressing and purifying this protein, structure determination is not far off.  
Recently, an undergraduate in the lab, Edward T. El Rassi, with Dr. Benson have 
transformed P6 into another vector that inserts a histidine tag for purification.  It has been 
confirmed that the cloning is correct and the protein is currently being over-expressed.  
The tag also allows for easy purification with a nickel affinity column.  Previous crystal 
screens have shown some promising crystallization possibilities, but as was done with 
Bam35 P3, more extensive work will need to be performed to find the ideal 
crystallization conditions for the P6 protein. 
 
 Obtaining structures for these two proteins is the ultimate goal.  However, this 
work will have to be carried out in the future.  Preliminary data from Bam35 P3 does 
continue to point in the direction of putting it into the proposed lineage.  Verifying the 
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structure of the PRD1 P6 protein will need to be followed up with other proteins of the 
special vertex of other viruses to see if the ancestral lineage continues to be validated. 
 
 The knowledge of structures, while certainly giving insight into functions, 
packaging, and assembly, would hopefully lead into a much broader advantage.  That 
being the ability to use the knowledge of shared traits among viruses to interrupt their 
ability to package their nucleic acid and/or infect their hosts.  Thus, being able to prevent 
disease in humans, animals, plants, and so forth.  In essence, this would lead to the 
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